Jaimie Z. Shing, Ph.D., M.P.H.
NCI Shady Grove | Room 6E230
Jaimie Z. Shing, Ph.D., M.P.H., joined the Infections and Immunoepidemiology Branch (IIB) as a postdoctoral fellow in June 2021 and was appointed as a staff scientist in April 2024. Dr. Shing received a dual B.S./M.P.H. in health promotion and behavior with a concentration in epidemiology in 2017 from the University of Georgia, Athens, where she was inducted into the Delta Omega Honorary Society in Public Health. In 2021, Dr. Shing earned her Ph.D. in epidemiology from Vanderbilt University, Nashville, Tennessee. Her doctoral research focused on assessing population-level human papillomavirus (HPV) vaccine impact and improving surveillance of cervical premalignant lesions using claims-based prediction models. In 2023, Dr. Shing was awarded the Division of Cancer Epidemiology and Genetics Fellows Award for Research Excellence and the Fellowship Achievement Award.
Dr. Shing supports Aimée R. Kreimer, Ph.D., senior investigator, IIB, on national and global studies of HPV-related cancers and health disparities. Dr. Shing’s research focuses on evaluating HPV vaccine efficacy, investigating biomarkers to identify HPV-related cancers, and examining HPV-related cancer health disparities. As the IIB Fellows Coordinator, Dr. Shing also provides mentorship and support to IIB fellows.